Site icon Fundorica

Novo Nordisk 3Q Sales DKK58.73B

By Dominic Chopping


Novo Nordisk is gradually expanding supply capacity for its blockbuster weight-loss drug, but said it will continue to limit supply of lower-strength doses of the Wegovy medicine in the U.S. as it seeks to safeguard supplies.


Write to Dominic Chopping at dominic.chopping@wsj.com

Read the full article here

Exit mobile version